MENU
ENTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Enanta Pharmaceuticals (ENTA) Ownership - Who owns Enanta Pharmaceuticals?
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
154.02M
P/E Ratio
N/A
Total Cash
216.69M
Projected Growth
N/A
Total Debt
57.46M
Revenue
66.59M
Risk (Beta)
0.50
Dividend Yield
N/A
Total Cash/Share
10.16
Total Debt/Equity
N/A
Revenue/Share
3.14 USD as % of share price
Fundamentals
ENTA
Capitalization
154M
P/E Ratio
N/A
Risk (Beta)
0.50
Dividend Yield
N/A
Total Cash
217M
Total Cash/Share
10.16
Total Debt
57.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.14%
Revenue
66.6M
ROE
N/A
Book Value
112M
P/B Ratio
1.38
Cash Flow
N/A
Earnings
-4.95
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
213K
Current Ratio
5.47
Current Revenue Per Employee
129458.02
Dividends Per Share - Security
N/A
EBITDA
-94.42M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.00
Shares Held By Institutions
141M
Shares Outstanding - Current
21.3M
Total Liabilities
237M
Total Volume MTD
N/A
Value
-1
Gain YTD
25.913
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs and other pharmaceuticals products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com